CIK 0001069530
- Non-accelerated filer
- Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 911911336
- Phone
- +1 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- 4 Shares withheld for taxes Chief Medical Officer gave up 23,996 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 4,387 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy President and CEO bought 10,000 shares at $9.59 ($95,900)
- 4 Open-market buy Director bought 36,281 shares at $8.92 ($323,627)
- 4 Open-market buy Chief Financial Officer bought 12,000 shares at an average $7.03 ($84,380)
- 4 Open-market buy Director bought 213,719 shares at $6.98 ($1,491,759)
- 4 Open-market buy President and CEO bought 100,000 shares at $5.53 ($553,000)
- 4 Open-market buy President and CEO bought 10,000 shares at $4.15 ($41,500)
- 4/A Open-market buy President and CEO bought 2,599 shares at $1.65 ($4,288)
- 4 Open-market buy President and CEO bought 2,599 shares at $1.65 ($4,288)
- 4 Open-market buy Director bought 423,788 shares at $2.20 ($932,334)
- 4 Open-market buy Chief Financial Officer bought 5,300 shares at $1.88 ($9,964)
- 4 Open-market buy Director bought 76,212 shares at $1.86 ($141,754)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 6 of 30 · 591 filings